```html

Juvenile Cytomegalovirus (CMV) Infection – A Complete Medical Guide

Overview

Cytomegalovirus (CMV) is a common member of the herpesvirus family. In most healthy children it causes a mild, “flu‑like” illness, but because the virus can remain latent and reactivate, it is a significant concern for infants, immunocompromised children, and newborns who acquire the infection congenitally.

• Who it affects: All children are susceptible after exposure, but the term “juvenile CMV infection” usually refers to cases in children < 18 years old, especially those under 5 years or those with weakened immunity.
• Prevalence: By age 5, > 60 % of children in the United States have been infected with CMV (CDC, 2022). In developing regions the seroprevalence can exceed 90 %.
• Transmission routes: Saliva, urine, breast‑milk, blood products, organ transplants, and vertical transmission from mother to fetus.

Most infections are asymptomatic; however, when symptoms appear they can mimic mononucleosis, gastroenteritis, or a simple viral illness.

Symptoms

Symptoms vary based on age, immune status, and whether the infection is primary or reactivation. Below is a comprehensive list with brief descriptions.

Common in Healthy Children (Typically 1–4 years)

• Fever: Low‑grade to high, lasting 3–7 days.
• Lethargy or irritability: Especially in infants.
• Loss of appetite (anorexia): May lead to mild weight loss.
• Rash: Pink‑red maculopapular rash, often beginning on the trunk.
• Sore throat & enlarged tonsils: Can mimic strep throat.
• Swollen lymph nodes: Particularly posterior cervical and axillary nodes.
• Hepatosplenomegaly: Mild enlargement of liver and spleen noted on exam.
• Transient liver enzyme elevation: Usually asymptomatic.

In Immunocompromised Children (e.g., transplant recipients, HIV, chemotherapy)

• Persistent high‑grade fever
• Severe pneumonia or interstitial lung disease
• Colitis with abdominal pain and bloody diarrhea
• CMV retinitis – vision changes, floaters, or loss of sight
• Encephalitis – confusion, seizures, focal neurologic deficits
• Hematologic abnormalities – neutropenia, thrombocytopenia

Congenital CMV (Newborns)

• Jaundice, hepatosplenomegaly
• Microcephaly or brain calcifications
• Sensorineural hearing loss (most common long‑term sequela)
• Small palpebral fissures, chorioretinitis

Causes and Risk Factors

CMV is a DNA virus spread through body fluids. Key points:

• Primary exposure: Close contact with infected children’s urine or saliva (e.g., sharing toys, diaper changes).
• Breast‑feeding: While breast‑milk is beneficial, it can contain CMV; most healthy infants handle it without issue.
• Blood transfusion or organ transplantation: If donor blood is not CMV‑negative.
• Maternal infection during pregnancy: Leads to congenital infection.

Risk Factors

• Day‑care attendance – > 30 % of children in day‑care acquire CMV each year (CDC).
• Immunosuppression – transplant recipients, children with congenital immunodeficiencies, HIV.
• Premature birth – preterm infants have underdeveloped immune systems.
• Close contact with CMV‑seropositive adults (e.g., healthcare workers, family members).

Diagnosis

Because the presentation overlaps with many viral illnesses, laboratory confirmation is essential.

Laboratory Tests

• CMV IgM antibody: Indicates recent primary infection; may persist for 2–3 months.
• CMV IgG serology: Shows past exposure; a rising IgG titre suggests recent infection.
• Polymerase chain reaction (PCR): Detects CMV DNA in blood, urine, saliva, or CSF—most sensitive, especially for immunocompromised patients.
• pp65 antigenemia assay: Used in transplant centers to quantify active infection.

Imaging & Specialty Tests (when indicated)

• Chest X‑ray or CT for pulmonary involvement.
• Abdominal ultrasound for hepatosplenomegaly.
• Fundoscopic exam for retinitis.
• Auditory brainstem response (ABR) testing in infants for hearing loss.

Treatment Options

Management depends on the child’s immune status and disease severity.

Supportive Care (Healthy Children)

• Hydration and antipyretics (acetaminophen or ibuprofen) for fever.
• Rest and a balanced diet.
• Monitoring for worsening symptoms—most recover spontaneously within 2–4 weeks.

Antiviral Therapy (Immunocompromised or Severe Disease)

Medication	Typical Dose (pediatric)	Key Side Effects
Ganciclovir (IV)	5 mg/kg every 12 h	Neutropenia, renal toxicity
Valganciclovir (oral)	7 mg/kg twice daily	Same as ganciclovir; easier outpatient use
Foscarnet (IV)	60 mg/kg every 8 h	Electrolyte abnormalities, nephrotoxicity
Cidofovir (IV)	5 mg/kg once weekly	Nephrotoxicity, ocular toxicity

Therapy is usually continued for 2–4 weeks and guided by viral load trends.

Adjunctive Measures

• Granulocyte colony‑stimulating factor (G‑CSF) for severe neutropenia.
• Intravenous immunoglobulin (IVIG) in selected congenital cases.

Lifestyle & Home‑Based Interventions

• Good hand hygiene – wash hands with soap for at least 20 seconds after diaper changes.
• Avoid sharing utensils, cups, or toothbrushes.
• For breast‑feeding mothers with active CMV shedding, discuss options with a pediatric infectious disease specialist.

Living with Juvenile Cytomegalovirus Infection

Even when the acute episode resolves, families may need ongoing strategies.

Regular Monitoring

• For immunocompromised kids, monthly PCR testing for the first 6 months, then quarterly.
• Infants with congenital infection should have hearing tests at birth, 6 months, and yearly through school age.

School & Day‑Care Considerations

• Inform caregivers of the child’s CMV status so they can reinforce hand‑washing.
• Children on antiviral therapy may need brief absences during infusion appointments.

Emotional & Psychological Support

• Explain the infection in age‑appropriate language to reduce anxiety.
• Connect families with support groups (e.g., CMV Foundation).

Nutrition & General Health

• Encourage a diet rich in fruits, vegetables, and protein to support immune recovery.
• Maintain up‑to‑date vaccinations—CMV does not interfere with routine immunizations.

Prevention

Because CMV is widespread, absolute prevention is impossible, but risk can be markedly reduced.

• Hand hygiene: Soap and water are superior to alcohol‑based rubs for removing CMV in urine.
• Safe diaper practices: Change diapers in a designated area; clean surfaces with bleach‑based disinfectant.
• Avoid sharing foods or drinks with young children, especially in day‑care settings.
• Blood product screening: Transfuse CMV‑negative or leukoreduced blood for high‑risk patients.
• Pregnant women: Practice strict hygiene when caring for toddlers; consider CMV serologic screening if high risk.

Complications

If left untreated or in vulnerable populations, CMV can lead to serious outcomes.

• Hematologic: Persistent anemia, neutropenia, thrombocytopenia.
• Neurologic: Encephalitis, seizures, developmental delay.
• Ophthalmologic: CMV retinitis → irreversible blindness if not promptly treated.
• Gastrointestinal: Severe colitis, ulceration, perforation.
• Pulmonary: Interstitial pneumonitis, respiratory failure.
• Long‑term sequelae in congenital infection: Hearing loss (affects ~10 % of symptomatic newborns), motor deficits, intellectual disability.

When to Seek Emergency Care

---

References:
1. Centers for Disease Control and Prevention. Cytomegalovirus (CMV) and Congenital CMV Infection. 2022.
2. Mayo Clinic. Cytomegalovirus (CMV) infection – Symptoms and causes. 2023.
3. NIH, National Institute of Allergy and Infectious Diseases. CMV Treatment Guidelines. 2021.
4. Cleveland Clinic. CMV in Immunocompromised Patients. 2022.
5. World Health Organization. Global Burden of CMV Infection. 2021.

```